Manufacturers of dietary supplements, food, beverages, and even medical devices can breathe a little easier following the Supreme Court’s denial of certiorari this week in a case seeking to overturn a First Circuit decision...more
4/18/2024
/ Denial of Certiorari ,
Dietary Supplements ,
False Advertising ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food & Drug Regulations ,
Food and Drug Administration (FDA) ,
Johnson & Johnson ,
Pharmaceutical Industry ,
Preemption ,
State Law Claims ,
Unfair or Deceptive Trade Practices